These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Melanocyte development and malignant melanoma. Goding CR Forum (Genova); 2000; 10(3):176-87. PubMed ID: 11007928 [TBL] [Abstract][Full Text] [Related]
9. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression. Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970 [TBL] [Abstract][Full Text] [Related]
10. The regulation of INK4/ARF in cancer and aging. Kim WY; Sharpless NE Cell; 2006 Oct; 127(2):265-75. PubMed ID: 17055429 [TBL] [Abstract][Full Text] [Related]
11. In vivo assessment of RAS-dependent maintenance of tumor angiogenesis by real-time magnetic resonance imaging. Tang Y; Kim M; Carrasco D; Kung AL; Chin L; Weissleder R Cancer Res; 2005 Sep; 65(18):8324-30. PubMed ID: 16166309 [TBL] [Abstract][Full Text] [Related]
12. Function of JunB in transient amplifying cell senescence and progression of human prostate cancer. Konishi N; Shimada K; Nakamura M; Ishida E; Ota I; Tanaka N; Fujimoto K Clin Cancer Res; 2008 Jul; 14(14):4408-16. PubMed ID: 18628455 [TBL] [Abstract][Full Text] [Related]
13. Tumor suppression for ARFicionados: the relative contributions of p16INK4a and p14ARF in melanoma. Peters G J Natl Cancer Inst; 2008 Jun; 100(11):757-9. PubMed ID: 18505965 [No Abstract] [Full Text] [Related]
15. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins. Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849 [TBL] [Abstract][Full Text] [Related]
16. Histopathological atlas and proposed classification for melanocytic lesions in Tyr::NRas(Q61K) ; Cdkn2a(-/-) transgenic mice. Campagne C; Reyes-Gomez E; Battistella M; Bernex F; Château-Joubert S; Huet H; Beermann F; Aubin-Houzelstein G; Egidy G Pigment Cell Melanoma Res; 2013 Sep; 26(5):735-42. PubMed ID: 23647911 [No Abstract] [Full Text] [Related]
17. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs). Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954 [TBL] [Abstract][Full Text] [Related]
18. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway. Chen RS; Song YM; Zhou ZY; Tong T; Li Y; Fu M; Guo XL; Dong LJ; He X; Qiao HX; Zhan QM; Li W Oncogene; 2009 Jan; 28(4):599-609. PubMed ID: 19015640 [TBL] [Abstract][Full Text] [Related]
19. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401 [TBL] [Abstract][Full Text] [Related]
20. The fibroblast growth factor-2 is not essential for melanoma formation in a transgenic mouse model. Ackermann J; Beermann F Pigment Cell Res; 2005 Aug; 18(4):315-9. PubMed ID: 16029424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]